Convenient In-Clinic Blood Withdrawal and Lab Services We aim to simplify the process of getting your lab work done
In a recent trial studying the effectiveness of tirzepatide (Zepbound) for weight loss, participants lost an average of 20.9% of their body weight at 36 weeks
Biotech Peptides offers a broad and competitively priced selection of popular research peptides
In the obese trial cohort, 1 mg moved 24-hour ambulatory heart rate by +0.7 bpm at week 24 the peak of the heart-rate curve, and below the placebo arms +0.8. In a healthy lean Phase 1 group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
Outcomes vary, and your baseline risk factors matter a lot
How This Compares to Tirzepatide's Approval Timeline Tirzepatide is the closest precedent Lilly has run